We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Roche is temporarily suspending recruitment in a study of anemic advanced lung cancer patients receiving chemotherapy after an “imbalance” of deaths across the four arms of the study, the company announced.
Women who take estrogen as hormone replacement therapy to counter the effects of menopause may be better off using a transdermal patch than swallowing a pill, according to a recent study.
GlaxoSmithKline (GSK) has alerted healthcare providers about the increased risk of fractures related to Avandia, Avandamet and Avandaryl tablets, which are used to treat Type 2 diabetes mellitus.
The FDA issued letters to manufacturers of all attention-deficit/hyperactivity disorder (ADHD) products asking them to implement new medication guides, saying it is concerned about cardiovascular risks and adverse psychiatric symptoms.
The healthcare advocacy group Community Catalyst has begun what it says is the first comprehensive campaign to conduct and publicize research on potential conflicts of interest arising from the $12 billion spent annually on pharmaceutical marketing directed at physicians.
Two companies announced they are taking steps to provide easier access to needed medications in developing countries, while an advocacy group claimed a third company is preventing access to AIDS medication through an overload of patents.
The healthcare advocacy group Community Catalyst has begun what it says is the first comprehensive campaign to conduct and publicize research on potential conflicts of interest arising from the $12 billion spent annually on pharmaceutical marketing directed at physicians.
CVS and Caremark downplayed investor recommendations made last week calling for shareholders to reject merging the companies, a plan that could generate combined projected revenue of $75 billion.